Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Direct Calculation of Protein Fitness Landscapes through Computational Protein Design.

Au L, Green DF.

Biophys J. 2016 Jan 5;110(1):75-84. doi: 10.1016/j.bpj.2015.11.029.

2.

A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR).

Fervenza FC, Canetta PA, Barbour SJ, Lafayette RA, Rovin BH, Aslam N, Hladunewich MA, Irazabal MV, Sethi S, Gipson DS, Reich HN, Brenchley P, Kretzler M, Radhakrishnan J, Hebert LA, Gipson PE, Thomas LF, McCarthy ET, Appel GB, Jefferson JA, Eirin A, Lieske JC, Hogan MC, Greene EL, Dillon JJ, Leung N, Sedor JR, Rizk DV, Blumenthal SS, Lasic LB, Juncos LA, Green DF, Simon J, Sussman AN, Philibert D, Cattran DC; Mentor Consortium group.

Nephron. 2015;130(3):159-68. doi: 10.1159/000430849. Epub 2015 Jun 12.

PMID:
26087670
3.

Tubulointerstitial nephritis accompanying gamma-heavy chain deposition and gamma-heavy chain restricted plasma cells in the kidney.

Nayer A, Green DF, Gonzalez-Suarez ML, Sujoy V, Ikpatt OF, Thomas DB.

Iran J Kidney Dis. 2014 Sep;8(5):417-23.

4.

Plasma exchange for concurrent lupus nephritis and antiphospholipid syndrome.

Sendzischew MA, Vieregge GB, Green DF, Contreras GN, Zeng X, Nayer A.

Clin Kidney J. 2014 Feb;7(1):86-9. doi: 10.1093/ckj/sft150. No abstract available.

5.

Catastrophic antiphospholipid syndrome with severe acute thrombotic microangiopathy and hemorrhagic complications.

Vieregge GB, Harrington TJ, Andrews DM, Carpintero MF, Green DF, Nayer A.

Case Rep Med. 2013;2013:915309. doi: 10.1155/2013/915309. Epub 2013 Dec 9.

6.

Rational modification of protein stability by targeting surface sites leads to complicated results.

Xiao S, Patsalo V, Shan B, Bi Y, Green DF, Raleigh DP.

Proc Natl Acad Sci U S A. 2013 Jul 9;110(28):11337-42. doi: 10.1073/pnas.1222245110. Epub 2013 Jun 24.

7.

Carbohydrate recognition by the antiviral lectin cyanovirin-N.

Fujimoto YK, Green DF.

J Am Chem Soc. 2012 Dec 5;134(48):19639-51. doi: 10.1021/ja305755b. Epub 2012 Nov 20.

8.

Ionic strength effects on amyloid formation by amylin are a complicated interplay among Debye screening, ion selectivity, and Hofmeister effects.

Marek PJ, Patsalo V, Green DF, Raleigh DP.

Biochemistry. 2012 Oct 30;51(43):8478-90. doi: 10.1021/bi300574r. Epub 2012 Oct 16.

9.

Biophysical and functional analyses suggest that adenovirus E4-ORF3 protein requires higher-order multimerization to function against promyelocytic leukemia protein nuclear bodies.

Patsalo V, Yondola MA, Luan B, Shoshani I, Kisker C, Green DF, Raleigh DP, Hearing P.

J Biol Chem. 2012 Jun 29;287(27):22573-83. doi: 10.1074/jbc.M112.344234. Epub 2012 May 9.

10.

Rational and computational design of stabilized variants of cyanovirin-N that retain affinity and specificity for glycan ligands.

Patsalo V, Raleigh DP, Green DF.

Biochemistry. 2011 Dec 13;50(49):10698-712. doi: 10.1021/bi201411c. Epub 2011 Nov 16.

11.

A Statistical Framework for Hierarchical Methods in Molecular Simulation and Design.

Green DF.

J Chem Theory Comput. 2010 May 11;6(5):1682-97. doi: 10.1021/ct9004504. Epub 2010 Apr 9.

PMID:
26615700
12.

Energetic decomposition with the generalized-born and Poisson-Boltzmann solvent models: lessons from association of G-protein components.

Carrascal N, Green DF.

J Phys Chem B. 2010 Apr 22;114(15):5096-116. doi: 10.1021/jp910540z.

PMID:
20355699
13.

Interpretation of p-cyanophenylalanine fluorescence in proteins in terms of solvent exposure and contribution of side-chain quenchers: a combined fluorescence, IR and molecular dynamics study.

Taskent-Sezgin H, Chung J, Patsalo V, Miyake-Stoner SJ, Miller AM, Brewer SH, Mehl RA, Green DF, Raleigh DP, Carrico I.

Biochemistry. 2009 Sep 29;48(38):9040-6. doi: 10.1021/bi900938z.

PMID:
19658436
14.

Computational models explain the oligosaccharide specificity of cyanovirin-N.

Fujimoto YK, Terbush RN, Patsalo V, Green DF.

Protein Sci. 2008 Nov;17(11):2008-14. doi: 10.1110/ps.034637.108. Epub 2008 Sep 22.

15.

Evaluation of electrostatic interactions.

Green DF, Tidor B.

Curr Protoc Bioinformatics. 2003 Aug;Chapter 8:Unit 8.3. doi: 10.1002/0471250953.bi0803s02.

PMID:
18428710
16.

Optimized parameters for continuum solvation calculations with carbohydrates.

Green DF.

J Phys Chem B. 2008 Apr 24;112(16):5238-49. doi: 10.1021/jp709725b. Epub 2008 Apr 3.

PMID:
18386862
17.
18.

Rational design of new binding specificity by simultaneous mutagenesis of calmodulin and a target peptide.

Green DF, Dennis AT, Fam PS, Tidor B, Jasanoff A.

Biochemistry. 2006 Oct 17;45(41):12547-59.

20.

Action-at-a-distance interactions enhance protein binding affinity.

Joughin BA, Green DF, Tidor B.

Protein Sci. 2005 May;14(5):1363-9. Epub 2005 Mar 31.

21.

High throughput screening via mass spectrometry: a case study using acetylcholinesterase.

Ozbal CC, LaMarr WA, Linton JR, Green DF, Katz A, Morrison TB, Brenan CJ.

Assay Drug Dev Technol. 2004 Aug;2(4):373-81.

PMID:
15357918
22.
23.

X-ray structural and simulation analysis of a protein mutant: the value of a combined approach.

Mattos C, Cohen JD, Green DF, Tidor B, Karplus M.

Proteins. 2004 May 15;55(3):733-42.

PMID:
15103635
24.

Conformational preferences in glycosylamines. implications for the exo-anomeric effect.

Batchelor RJ, Green DF, Johnston BD, Patrick BO, Pinto BM.

Carbohydr Res. 2001 Feb 15;330(3):421-6.

PMID:
11270822
25.

Gender, body mass and age as risk factors for ulnar mononeuropathy at the elbow.

Richardson JK, Green DF, Jamieson SC, Valentin FC.

Muscle Nerve. 2001 Apr;24(4):551-4.

27.
28.

Spinal myoclonus complicating spasticity in spinal cord injury: a case study.

Andary MT, Green DF, Hulce VD, Pysh JJ.

Arch Phys Med Rehabil. 1997 Sep;78(9):1007-9.

PMID:
9305277
29.

Systemic lupus erythematosus in two adults with human immunodeficiency virus infection.

Contreras G, Green DF, Pardo V, Schultz DR, Bourgoignie JJ.

Am J Kidney Dis. 1996 Aug;28(2):292-5. Review. No abstract available.

PMID:
8768929
30.

Microscopic visualization of Wuchereria and Brugia larval stages in intact cleared mosquitoes.

Green DF, Yates JA.

Am J Trop Med Hyg. 1994 Oct;51(4):483-8.

PMID:
7943576
31.

Uptake of atrial natriuretic peptide and production of cGMP in cultured human glomerular endothelial cells.

Green DF, Duruibe VA, Blyden G, Laskey RE, Bourgoignie JJ.

J Am Soc Nephrol. 1994 Oct;5(4):1091-8.

32.

Culture of endothelial cells from baboon and human glomeruli.

Green DF, Hwang KH, Ryan US, Bourgoignie JJ.

Kidney Int. 1992 Jun;41(6):1506-16.

33.

HIV infects glomerular endothelial and mesangial but not epithelial cells in vitro.

Green DF, Resnick L, Bourgoignie JJ.

Kidney Int. 1992 Apr;41(4):956-60.

34.

Race, a cofactor in HIV-1-associated nephropathy.

Bourgoignie JJ, Ortiz-Interian C, Green DF, Roth D.

Transplant Proc. 1989 Dec;21(6):3899-901. No abstract available.

PMID:
2609400
35.

Urodynamic studies in patients undergoing bladder replacement surgery.

Lytton B, Green DF.

J Urol. 1989 Jun;141(6):1394-7.

PMID:
2724438
36.

Electrohydraulic lithotripsy in the ureter.

Green DF, Lytton B.

Urol Clin North Am. 1988 Aug;15(3):361-4.

PMID:
3407027
37.

Microtitre plate method for alanine transferase (ALT) assays.

Archer AC, Green DF, Buckland EJ.

J Clin Pathol. 1988 Aug;41(8):918-9.

38.

The effect of electroconvulsive therapy on CSF amine metabolites in schizophrenic patients.

Cooper SJ, Leahey W, Green DF, King DJ.

Br J Psychiatry. 1988 Jan;152:59-63.

PMID:
2458796
39.

Ureteropelvic junction obstruction after percutaneous nephrolithotripsy.

Green DF, Lytton B, Glickman M.

J Urol. 1987 Sep;138(3):599-602.

PMID:
3625864
40.

Complications of ureteral endoscopy.

Lytton B, Weiss RM, Green DF.

J Urol. 1987 Apr;137(4):649-53.

PMID:
3550147
42.

Incarcerated ileal loop and inguinal hernia.

Green DF, Dodds P.

Urology. 1986 Jun;27(6):546-7. No abstract available.

PMID:
3716055
43.

Acute adrenal insufficiency as a complication of urological surgery.

Jacobson SA, Blute RD Jr, Green DF, McPhedran P, Weiss RM, Lytton B.

J Urol. 1986 Feb;135(2):337-40.

PMID:
3944871
44.
45.

Does intravesical chemotherapy prevent invasive bladder cancer?

Green DF, Robinson MR, Glashan R, Newling D, Dalesio O, Smith PH.

J Urol. 1984 Jan;131(1):33-5.

PMID:
6418897
46.

Asepsis and out-patient cystoscopy.

Fozard JB, Green DF, Harrison GS, Smith PH, Zoltie N.

Br J Urol. 1983 Dec;55(6):680-3.

PMID:
6652438
47.

A phase II study of intravesical mitomycin C in the treatment of superficial bladder cancer.

Harrison GS, Green DF, Newling DW, Richards B, Robinson MR, Smith PH.

Br J Urol. 1983 Dec;55(6):676-9.

PMID:
6418263
48.

[Cancer of the bladder. Diagnosis and staging].

Smith PH, Green DF.

Arch Esp Urol. 1982 Nov-Dec;35(6):376-80. Spanish. No abstract available.

PMID:
7165402
49.

The choice of surgical incision.

Smith PH, Green DF.

Prog Clin Biol Res. 1982;100:471-3. No abstract available.

PMID:
7145973
50.

A proposal to modernize the american antiquities act.

Collins RB, Green DF.

Science. 1978 Dec 8;202(4372):1055-9.

PMID:
17777944

Supplemental Content

Loading ...
Support Center